Page 32 - Dwight Egan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

-- Co-Diagnostics, Inc.  (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that its Logix Smart™ COVID-19 Test Kit was used by Australian researchers to demonstrate rapidly deployable mobile molecular diagnostics support for remote locations, with the peer-reviewed results published in the Journal of Medical Microbiology. The study was performed using readily available open-source equipment and materials that could be successfully operated in regional clinical laboratories, many of which are not curr...

Co-Diagnostics says Logix Smart COVID-19 Test performance validated by Australian researchers in peer-reviewed publication A paper published in the Journal of Medical Microbiology utilizes the company's Logix Smart COVID-19 Test Kit in rapidly deployable mobile molecular diagnostics Co-Diagnostics CEO Dwight Egan said the results of the 'independent peer-reviewed paper further establishes the robustness, versatility, and quality of our Logix Smart COVID-19 diagnostic' Co-Diagnostics Inc (NASDAQ:CODX), a molecular diagnostics company with a patented platform for the development of ...

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of...

Share this article SALT LAKE CITY, March 8, 2021 /PRNewswire/ -- Co-Diagnostics, Inc.  (NASDAQ-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Company CEO Dwight Egan will present at the 2021 H.C. Wainwright & Co. Global Life Sciences Conference, being held virtually on March 9-10. Participants can register for the conference here. An archived version of the presentation can be accessed on the Events and Webcasts section of the Co-Diagnostics website following the conclusion o...

Share this article SALT LAKE CITY, Feb. 16, 2021 /PRNewswire/ -- Co-Diagnostics, Inc.  (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that it will be presenting on direct saliva testing for COVID-19 at the 28 th Annual International Molecular Medicine Tri-Conference, held virtually on February 16-18, 2021. Company representatives will introduce the Co-Diagnostics Logix Smart SARS-CoV-2 DS (Direct Saliva) kit, which the Company has submitted for Emergency Use Authorization (EUA) to the US Food and Drug...